03 Signed research contract with University of Chicago
2023
01 Signed MoU with Elketa 05 Signed MoU with Weknew 08 Established Oncosoft USA Inc. 08 Signed contract with Japan M3 AI 09 Signed MoU with Yonsei Digital Health Center 10 Held the 1st User Meeting ‘OncoBUS’ 11 Signed MoU with Terapet SA 11 Signed MoU with Yonsei Cancer Hospital Heavy Ion Therapy Center 12 Signed contract with Gachon University Gil Medical Center
2022
02 Acquired KFDA class II medical device certification for AI-based auto-segmentation solution 03 Commercialized OncoStudio (AI-based auto segmentation SW) 09 Investment of KRW 35B (Series A)
2021
03 Established Corporate R&D Center 07 Investment of KRW 500M (Series Pre-A) 11 Acquired Good Manufacturing Practice (GMP) certification for medical device manufacturing and quality management
2020
10 Investmentof KRW 150M (Seed)
2019
09 EstablishedOncosoft Inc. 10 Ranked3rd in AAPM’s ‘RT-MAC Challenge’
